Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, June 29, 2015, 42 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $800.00 to $5,120,921.47.

Highlighted Stocks Traded by Insiders:

Escalade (ESCA) - FREE Research Report

Savitsky George, who is Director at Escalade, sold 5,000 shares at $19.05 on June 29, 2015. Following this transaction, the Director owned 37,500 shares meaning that the stake was reduced by 11.76% with the 5,000-share transaction.

The shares most recently traded at $18.58, down $0.47, or 2.55% since the insider transaction. Historical insider transactions for Escalade go as follows:

  • 4-Week # shares sold: 3,000
  • 12-Week # shares sold: 4,728
  • 24-Week # shares sold: 4,728

The average volume for Escalade has been 24,400 shares per day over the past 30 days. Escalade has a market cap of $270.0 million and is part of the consumer goods sector and consumer durables industry. Shares are up 27.5% year-to-date as of the close of trading on Monday.

Escalade, Incorporated, together with its subsidiaries, manufactures and sells sporting goods to retailers, dealers, and wholesalers primarily in North America and Europe. The stock currently has a dividend yield of 2.29%. The company has a P/E ratio of 18.5. Currently, there are 2 analysts who rate Escalade a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on ESCA - FREE

TheStreet Quant Ratings

rates Escalade as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, growth in earnings per share and compelling growth in net income. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full

Escalade Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Cantel Medical (CMN) - FREE Research Report

Hansen Jorgen B, who is President and COO at Cantel Medical, sold 1,500 shares at $52.79 on June 29, 2015. Following this transaction, the President and COO owned 41,403 shares meaning that the stake was reduced by 3.5% with the 1,500-share transaction.

The shares most recently traded at $53.66, up $0.87, or 1.62% since the insider transaction. Historical insider transactions for Cantel Medical go as follows:

  • 4-Week # shares sold: 31,500
  • 12-Week # shares sold: 50,446
  • 24-Week # shares sold: 104,310

The average volume for Cantel Medical has been 122,600 shares per day over the past 30 days. Cantel Medical has a market cap of $2.2 billion and is part of the health care sector and health services industry. Shares are up 24.62% year-to-date as of the close of trading on Monday.

Cantel Medical Corp. provides infection prevention and control products and services in the healthcare market. The stock currently has a dividend yield of 0.19%. The company has a P/E ratio of 49.9. Currently, there is 1 analyst who rates Cantel Medical a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CMN - FREE

TheStreet Quant Ratings

rates Cantel Medical as a

buy

. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income, robust revenue growth, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full

Cantel Medical Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Skechers USA (SKX) - FREE Research Report

Rappaport Richard, who is Director at Skechers USA, sold 1,000 shares at $112.00 on June 29, 2015. Following this transaction, the Director owned 9,000 shares meaning that the stake was reduced by 10% with the 1,000-share transaction.

The shares most recently traded at $110.54, down $1.46, or 1.32% since the insider transaction. Historical insider transactions for Skechers USA go as follows:

  • 4-Week # shares sold: 5,413
  • 12-Week # shares sold: 14,413
  • 24-Week # shares sold: 42,570

The average volume for Skechers USA has been 1.1 million shares per day over the past 30 days. Skechers USA has a market cap of $4.7 billion and is part of the consumer goods sector and consumer non-durables industry. Shares are up 101.79% year-to-date as of the close of trading on Monday.

Skechers U.S.A., Inc. designs, develops, markets, and distributes footwear for men, women, and children, as well as performance footwear for men and women under the Skechers GO brand name. The company has a P/E ratio of 34.7. Currently, there are 6 analysts who rate Skechers USA a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SKX - FREE

TheStreet Quant Ratings

rates Skechers USA as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full

Skechers USA Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.